Policies and Regulation

Important Information

Global Investors (ex US). This website is operated jointly by Osmosis Investment Management UK Limited (“Osmosis UK”), authorised and regulated by the Financial Conduct Authority (FCA) in the United Kingdom (FRN: 765056) and Osmosis Investment Management NL B.V. (“Osmosis NL”), authorised and regulated by the Netherlands Authority for the Financial Markets (AFM) as an alternative investment fund manager with a MiFID II authorisation for discretionary portfolio management, and (together, “Osmosis”, “we” or “us”). Where information, strategies, products or documents on this website relate specifically to Osmosis UK or to Osmosis NL, this is stated on the relevant page and in the relevant document. Osmosis NL is an affiliate of Osmosis UK. Osmosis UK is wholly owned by London-based financial services holding group Osmosis (Holdings) Limited.

Professional investors only. Osmosis UK and Osmosis NL are each authorised to provide services only to professional clients and eligible counterparties as defined under FCA rules (and, for Osmosis NL, the equivalent MiFID II rules). This website, and all information, strategies and products described on it, are intended exclusively for such professional investors. It is not directed at, and must not be relied upon by, retail investors. By entering you confirm that you are a professional investor acting in a professional capacity.

No offer or solicitation. Nothing on this website constitutes, or is intended to constitute, an offer, invitation, solicitation or recommendation to buy, sell or subscribe for any financial instrument or to use any investment service, in any jurisdiction in which such an offer or solicitation is not authorised, or to any person to whom it is unlawful to make it. The information is provided for general information purposes only. It does not constitute investment, legal, tax or other advice, and no investment decision should be made on the basis of it.

Territorial scope. The services described on this website are provided by Osmosis UK and/or Osmosis NL only in the jurisdictions in which the relevant entity holds the necessary authorisation. Osmosis UK is authorised in the United Kingdom. Osmosis NL is authorised in the Netherlands and has passported its services into the following EU Member States: Belgium, Finland, Germany, Ireland, Luxemburg, Spain and Sweden. The fund products referred to are sub-funds of Irish UCITS, managed by an independent management company, in respect of which Osmosis UK and Osmosis NL act as sub-investment manager and as (sub-)distributor. One or more of the sub-funds are currently notified or registered for marketing only in the following jurisdictions: Austria, Belgium, Denmark, Finland, France, Italy, Luxembourg, Norway, Sweden, Spain, Switzerland, Netherlands, United Kingdom, Germany, and Italy. They are not notified or registered for marketing in, and are not being offered or marketed in, any other jurisdiction.

Access from other jurisdictions. This website is not directed at persons located or resident in any jurisdiction other than those listed above, and in particular is not directed at any person in any jurisdiction where the products, services or information described would be contrary to local law or regulation. If you access this website from any such other jurisdiction, you do so entirely on your own initiative and at your own risk, and you are solely responsible for compliance with the laws and regulations applicable to you. No product or service is offered or marketed to you, and none of the information on this website is directed at you. You may view the information, but you may not treat it as an offer or solicitation of any kind.

Important Information

Global Investors (ex US). This website is operated jointly by Osmosis Investment Management UK Limited (“Osmosis UK”), authorised and regulated by the Financial Conduct Authority (FCA) in the United Kingdom (FRN: 765056) and Osmosis Investment Management NL B.V. (“Osmosis NL”), authorised and regulated by the Netherlands Authority for the Financial Markets (AFM) as an alternative investment fund manager with a MiFID II authorisation for discretionary portfolio management, and (together, “Osmosis”, “we” or “us”). Where information, strategies, products or documents on this website relate specifically to Osmosis UK or to Osmosis NL, this is stated on the relevant page and in the relevant document. Osmosis NL is an affiliate of Osmosis UK. Osmosis UK is wholly owned by London-based financial services holding group Osmosis (Holdings) Limited.

Professional investors only. Osmosis UK and Osmosis NL are each authorised to provide services only to professional clients and eligible counterparties as defined under FCA rules (and, for Osmosis NL, the equivalent MiFID II rules). This website, and all information, strategies and products described on it, are intended exclusively for such professional investors. It is not directed at, and must not be relied upon by, retail investors. By entering you confirm that you are a professional investor acting in a professional capacity.

No offer or solicitation. Nothing on this website constitutes, or is intended to constitute, an offer, invitation, solicitation or recommendation to buy, sell or subscribe for any financial instrument or to use any investment service, in any jurisdiction in which such an offer or solicitation is not authorised, or to any person to whom it is unlawful to make it. The information is provided for general information purposes only. It does not constitute investment, legal, tax or other advice, and no investment decision should be made on the basis of it.

Territorial scope. The services described on this website are provided by Osmosis UK and/or Osmosis NL only in the jurisdictions in which the relevant entity holds the necessary authorisation. Osmosis UK is authorised in the United Kingdom. Osmosis NL is authorised in the Netherlands and has passported its services into the following EU Member States: Belgium, Finland, Germany, Ireland, Luxemburg, Spain and Sweden. The fund products referred to are sub-funds of Irish UCITS, managed by an independent management company, in respect of which Osmosis UK and Osmosis NL act as sub-investment manager and as (sub-)distributor. One or more of the sub-funds are currently notified or registered for marketing only in the following jurisdictions: Austria, Belgium, Denmark, Finland, France, Italy, Luxembourg, Norway, Sweden, Spain, Switzerland, Netherlands, United Kingdom, Germany, and Italy. They are not notified or registered for marketing in, and are not being offered or marketed in, any other jurisdiction.

Access from other jurisdictions. This website is not directed at persons located or resident in any jurisdiction other than those listed above, and in particular is not directed at any person in any jurisdiction where the products, services or information described would be contrary to local law or regulation. If you access this website from any such other jurisdiction, you do so entirely on your own initiative and at your own risk, and you are solely responsible for compliance with the laws and regulations applicable to you. No product or service is offered or marketed to you, and none of the information on this website is directed at you. You may view the information, but you may not treat it as an offer or solicitation of any kind.

Important Information

This document must not be acted or relied upon by persons who are not Professional Clients. Any investment or investment activity to which this document relates is available only to Professional Clients and will be engaged in only with Professional Clients. The content of this website is intended for eligible investors (as such term is defined in any given jurisdiction). Before acting on any information on this website you should be well informed of and observe all applicable laws, rules and regulations of your home jurisdiction and obtain independent advice if required.

US Investors. This website is issued by Osmosis Investment Management US LLC (“Osmosis US”). Osmosis US is regulated by the U.S. Securities and Exchange Commission ("SEC"). Osmosis US is an affiliate of Osmosis UK and Osmosis AUS. Osmosis UK, Osmosis US and Osmosis AUS are wholly owned subsidiaries of Osmosis (Holdings) Limited (“OHL”). Osmosis NL is an affiliate of Osmosis UK and member of the Osmosis Group of Companies. They are all collectively referred to throughout as “Osmosis”.

Information on this website is intended to be viewed in its entirety. The reproduction, downloading, streaming or other disclosure of such information, in whole or in part, without prior consent of Osmosis is prohibited. Neither this website, nor any copy of the information available on it, may be taken into or transmitted in any jurisdiction where it would be unlawful to do so.

The information contained in this document has been obtained by Osmosis from sources it believes to be reliable, accurate, and current as of the date of this material, but is subject to change without notice.. Information contained in this document may comprise an internal analysis performed by Osmosis and be based on the subjective views of, and various assumptions made by Osmosis at the date of this document.

Investments like these are not suitable for most investors as they are speculative and involve a high degree risk, including risk of loss of capital. There is no assurance that any implied or stated objectives will be met. Past performance is no guarantee of future results.

This document alone does not constitute: a recommendation by, or advice from, Osmosis or any other person to a recipient of this document on the merits or otherwise of participating in the products, investments and transactions referred to in this document; a guarantee, forecast, projection or estimate of any future returns (or cash flows) on any investment; or investment, tax or other advice. References to specific securities, asset classes and financial markets are for illustrative purposes only and are not intended to be, and should not be, interpreted as recommendations. The material was prepared without regard to specific objectives, financial situation or needs of any investor and should not be used as the basis of any investment decision. Potential investors should read the relevant fund's prospectus or offering memorandum, and consult their own legal, tax, accounting and other professional advisers before making any investment.